JTT-861

· Akros Pharma Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JTT-861, covering 2026-02-09 to 2026-02-09. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction [Phase 2]

See pricing